Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Patient Monitoring

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1728571

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1728571

Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2030

PUBLISHED:
PAGES: 265 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global sleep apnea oral appliances market is projected to reach USD 0.8 billion by 2030 from USD 0.5 billion in 2025, at a CAGR of 9.8% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Gender, Purchase Type, Age Group, Distribution Channel, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA

The market is experiencing growth due to a rise in lifestyle-related disorders such as diabetes, hypertension, and obesity, which can lead to obstructive sleep apnea and make it difficult for patients to breathe. There is also a growing awareness of sleep apnea and its management and treatment options. Furthermore, leading players in the industry are introducing innovative products and expanding their portfolios. These companies offer a variety of advanced, non-invasive oral appliances that are adjustable to meet patients' needs better.

By end user, the home care settings/individuals segment is expected to dominate the market during the forecast period.

By end users, the sleep apnea appliances market is segmented into clinics, hospitals, and home care settings/individuals. The home care settings/individuals segment accounted for the largest share of the market in 2024. The key factor contributing to market growth in this segment includes the preference of adopting sleep apnea devices in these settings owing to ease of convenience, remote availability, and cost-efficiency compared to hospitalization. These devices are covered by insurance or reimbursement policies. The home care setting is a growing market due to the increasing prevalence of sleep apnea, particularly in developed regions like North America and Europe. This rise is primarily attributed to the lifestyle choices common in these areas. Additionally, the accessibility of home sleep apnea tests is a significant factor contributing to the growth of the sleep apnea oral appliances market.

By distribution channel, the retail pharmacies segment accounted for the largest market share in 2024.

By distribution channel, the sleep apnea oral appliances market is divided into online pharmacies, retail pharmacies, and hospital pharmacies & dental clinics. Among these, the retail pharmacies segment accounted for the largest market share in 2024 owing to the increasing availability of oral sleep apnea appliances in retail pharmacies and the rising establishment of these settings in emerging markets. There is a growing awareness of the risks associated with undiagnosed sleep apnea, leading to an increased demand for oral appliances. This has resulted in zero waiting times at retail pharmacies, which offer a variety of devices that vary in affordability and quality.

The Asia Pacific region is expected to grow at the highest CAGR during the forecast period.

The global sleep apnea oral appliances market is segmented into five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is the fastest-growing regional sleep apnea organ appliance market. The key factors contributing to the high growth rate of the Asia Pacific market are the presence of manufacturing & distribution companies in the region. Some key players have recently expanded their presence in the Asia Pacific by setting up a manufacturing plant for oral appliances. Additionally, advancements in infrastructure and technology in the healthcare sector in the Asia Pacific market are increasing.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-50%, and Tier 3- 10%
  • By Designation: C-level-48%, Director-level-37% and Others-15%
  • By Region: North America-46%, Europe-26%, Asia Pacific-15%, Latin America- 6%, the Middle East & Africa - 4%, and GCC Countries - 3%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The leading players operating in the sleep apnea oral appliances market are SomnoMed (Australia), Resmed (US), ProSomnus Sleep Technologies (US), DynaFlex (US), Vivos Therapeutics, Inc. (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC (US), and Braebon Medical Corporation (Canada).

Research Coverage

This report studies the sleep apnea oral appliances market based on product, gender, purchase type, age group, distribution channel, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments about five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help established and new or smaller firms understand the market dynamics, allowing them to capture a larger market share. Companies that purchase the report can implement one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights on the following pointers:

  • Analysis of key drivers (Large pool of undiagnosed sleep apnea patients globally, growing awareness about effects of untreated sleep apnea among patients, rising usage of oral appliances among patients with mild-to-moderate sleep apnea, and the increasing number of companies in sleep apnea devices and oral appliances market), restraints (high prices of customized oral appliances, alternative therapies and medications for sleep apnea, risks associated with oral appliance therapy for obstructive sleep apnea), opportunities (growing demand for home sleep apnea tests as cost-saving measures; increasing focus on telemedicine, mhealth, and AI; poor compliance associated with CPAP) and challenges (complex referral pathways and long waiting periods) influencing the growth of the sleep apnea oral appliances market)
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the sleep apnea oral appliances market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the sleep apnea oral appliances market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the sleep apnea oral appliances market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Show more
Product Code: MD 6285

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED & GEOGRAPHIC SPREAD
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
      • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.2.1.3 Approach 3: Primary interviews
      • 2.2.1.4 Approach 4: Growth Forecast
      • 2.2.1.5 CAGR projections
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 RESEARCH LIMITATIONS
  • 2.5 RESEARCH ASSUMPTIONS
    • 2.5.1 STUDY-RELATED ASSUMPTIONS
    • 2.5.2 GROWTH RATE ASSUMPTIONS
  • 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 SLEEP APNEA ORAL APPLIANCES MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2025 VS. 2030
  • 4.3 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT AND COUNTRY (2024)
  • 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Large pool of undiagnosed sleep apnea patients
      • 5.2.1.2 Growing awareness associated with effects of untreated sleep apnea
      • 5.2.1.3 Increasing usage of oral appliances among patients with mild-to-moderate sleep apnea
      • 5.2.1.4 Entry of established companies with advanced sleep apnea oral solutions
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High price of customized oral appliances
      • 5.2.2.2 Alternative therapies & medications for sleep apnea
      • 5.2.2.3 Risks associated with oral appliance therapy for obstructive sleep apnea
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising demand for at-home sleep apnea tests
      • 5.2.3.2 Increasing importance of telemedicine, mHealth, and AI
      • 5.2.3.3 Poor compliance and low adherence associated with CPAP
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Complex referral pathways and long waiting periods
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023-2025
    • 5.3.2 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL PRODUCTS, BY KEY PLAYER, 2023-2025
    • 5.3.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023-2025
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 REGULATORY LANDSCAPE
      • 5.8.1.1 North America
        • 5.8.1.1.1 US
          • 5.8.1.1.1.1 Reimbursement scenario in US
        • 5.8.1.1.2 Canada
      • 5.8.1.2 Europe
      • 5.8.1.3 Asia Pacific
        • 5.8.1.3.1 Japan
        • 5.8.1.3.2 China
        • 5.8.1.3.3 India
        • 5.8.1.3.4 Australia
    • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.8.2.1 North America
      • 5.8.2.2 Europe
      • 5.8.2.3 Asia Pacific
      • 5.8.2.4 Latin America
      • 5.8.2.5 Middle East & Africa
  • 5.9 TRADE ANALYSIS
    • 5.9.1 TRADE ANALYSIS FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES
  • 5.10 PATENT ANALYSIS
  • 5.11 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 BUYING CRITERIA
  • 5.14 IMPACT OF GENERATIVE AI ON SLEEP APNEA ORAL APPLIANCES MARKET
    • 5.14.1 INTRODUCTION
    • 5.14.2 MARKET POTENTIAL FOR SLEEP APNEA ORAL APPLIANCES
    • 5.14.3 FUTURE OF GENERATIVE AI IN SLEEP APNEA ORAL APPLIANCES MARKET
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 TECHNOLOGY ANALYSIS
    • 5.16.1 KEY TECHNOLOGIES
      • 5.16.1.1 Mandibular advancement devices
    • 5.16.2 ADJACENT TECHNOLOGIES
      • 5.16.2.1 Daytime-nighttime appliances
  • 5.17 END-USER PERCEPTION ANALYSIS
  • 5.18 PURCHASE DECISION-MAKING PROCESS
    • 5.18.1 INTRODUCTION
      • 5.18.1.1 Need recognition
      • 5.18.1.2 Gathering information
      • 5.18.1.3 Evaluating alternatives
  • 5.19 TRUMP TARIFF IMPACT ON SLEEP APNEA ORAL APPLIANCES MARKET
    • 5.19.1 INTRODUCTION
    • 5.19.2 KEY TARIFF RATES

6 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 MANDIBULAR ADVANCEMENT DEVICES
    • 6.2.1 READY-MADE MANDIBULAR ADVANCEMENT DEVICES
      • 6.2.1.1 Low cost of ready-made MADs to boost demand
    • 6.2.2 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES
      • 6.2.2.1 High efficacy of custom-made MADs to support market growth
  • 6.3 TONGUE-RETAINING DEVICES
    • 6.3.1 LOWER SUCCESS RATE OF TRDS TO HINDER MARKET GROWTH
  • 6.4 DAYTIME-NIGHTTIME APPLIANCES
    • 6.4.1 INCREASING COMFORT & CONVENIENCE TO FUEL MARKET

7 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE

  • 7.1 INTRODUCTION
  • 7.2 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES
    • 7.2.1 FAILURE ASSOCIATED WITH CPAP THERAPY TO BOOST DEMAND
  • 7.3 ONLINE OTC ORAL APPLIANCES
    • 7.3.1 LACK OF REGULATORY APPROVAL TO HINDER MARKET GROWTH

8 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER

  • 8.1 INTRODUCTION
  • 8.2 MALE PATIENTS
    • 8.2.1 INHERENT DIFFERENCES IN BODY ANATOMY TO FUEL UPTAKE
  • 8.3 FEMALE PATIENTS
    • 8.3.1 GROWING AWARENESS FOR IMPROVED DIAGNOSIS TO SUPPORT MARKET

9 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP

  • 9.1 INTRODUCTION
  • 9.2 BELOW 40 YEARS
    • 9.2.1 LOWER PREVALENCE OF OSA IN YOUNGER AGE GROUPS TO RESTRAIN MARKET
  • 9.3 BETWEEN 40-60 YEARS
    • 9.3.1 LIFESTYLE FACTORS TO CONTRIBUTE TO MARKET GROWTH
  • 9.4 ABOVE 60 YEARS
    • 9.4.1 AGE-ASSOCIATED DISORDERS TO SUPPORT MARKET GROWTH

10 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL

  • 10.1 INTRODUCTION
  • 10.2 ONLINE PHARMACIES
    • 10.2.1 RISING BENEFITS OFFERED BY E-COMMERCE TO PROPEL MARKET
  • 10.3 RETAIL PHARMACIES
    • 10.3.1 RISING ACCESSIBILITY TO WIDE RANGE OF ORAL APPLIANCES TO BOOST DEMAND
  • 10.4 HOSPITAL PHARMACIES & DENTAL CLINICS
    • 10.4.1 PROVISION OF MAD AND TRD DEVICES DURING ORAL PROCEDURES TO SUPPORT MARKET GROWTH

11 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 HOME CARE SETTINGS/INDIVIDUALS
    • 11.2.1 GROWING PATIENT PREFERENCE FOR REMOTE OSA SERVICES TO PROPEL MARKET
  • 11.3 HOSPITALS
    • 11.3.1 ABILITY TO PURCHASE ADVANCED SLEEP APNEA EQUIPMENT TO DRIVE MARKET
  • 11.4 DENTAL CLINICS
    • 11.4.1 INCREASING ESTABLISHMENT OF PRIVATE DENTAL PRACTICES TO SUPPORT MARKET GROWTH

12 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 Favorable reimbursements and regulatory support to fuel market
    • 12.2.3 CANADA
      • 12.2.3.1 Increasing number of research grants for awareness of sleep disorders to drive market
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 GERMANY
      • 12.3.2.1 High prevalence of smokers and favorable health insurance coverage to fuel market
    • 12.3.3 UK
      • 12.3.3.1 Rising awareness among patients and increasing number of sleep service groups to support market
    • 12.3.4 FRANCE
      • 12.3.4.1 Expanding geriatric population and growing awareness of early diagnosis for OSA to drive market
    • 12.3.5 ITALY
      • 12.3.5.1 High prevalence of obesity and CVD to fuel market
    • 12.3.6 SPAIN
      • 12.3.6.1 Growing focus on telemedicine and remote monitoring of OSA patients to drive market
    • 12.3.7 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 CHINA
      • 12.4.2.1 Rising geriatric population and increasing cases of obesity to boost demand
    • 12.4.3 JAPAN
      • 12.4.3.1 Rising demand for cloud-connected sleep apnea therapeutic devices to fuel uptake
    • 12.4.4 AUSTRALIA
      • 12.4.4.1 Launch of technologically advanced OSA devices to aid market growth
    • 12.4.5 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 POOR HEALTHCARE INFRASTRUCTURE AND LIMITED PUBLIC HEALTH INITIATIVES TO RESTRAIN MARKET
    • 12.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
    • 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 12.7 GCC COUNTRIES
    • 12.7.1 HIGH OBESITY RATE AMONG WOMEN TO SUPPORT MARKET GROWTH
    • 12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET
  • 13.3 REVENUE ANALYSIS, 2022-2024
  • 13.4 MARKET SHARE ANALYSIS, 2024
    • 13.4.1 RANKING OF KEY MARKET PLAYERS
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Product footprint
      • 13.5.5.4 Purchase type footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 13.6.5.1 Detailed list of key startups/SMEs
      • 13.6.5.2 Competitive benchmarking of key startups/SMEs
  • 13.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 13.7.1 COMPANY VALUATION
    • 13.7.2 FINANCIAL METRICS
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES & APPROVALS
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS
    • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 SOMNOMED
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products offered
      • 14.1.1.3 MnM view
        • 14.1.1.3.1 Key strengths
        • 14.1.1.3.2 Strategic choices
        • 14.1.1.3.3 Weaknesses & competitive threats
    • 14.1.2 RESMED
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products offered
        • 14.1.2.2.1 Deals
        • 14.1.2.2.2 Expansions
      • 14.1.2.3 MnM view
        • 14.1.2.3.1 Key strengths
        • 14.1.2.3.2 Strategic choices
        • 14.1.2.3.3 Weaknesses & competitive threats
    • 14.1.3 PROSOMNUS SLEEP TECHNOLOGIES
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Deals
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses & competitive threats
    • 14.1.4 DYNAFLEX
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Deals
    • 14.1.5 VIVOS THERAPEUTICS, INC.
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Product approvals
        • 14.1.5.3.2 Deals
        • 14.1.5.3.3 Expansions
        • 14.1.5.3.4 Other developments
    • 14.1.6 OPENAIRWAY
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Deals
    • 14.1.7 PANTHERA DENTAL
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Product launches
        • 14.1.7.3.2 Deals
        • 14.1.7.3.3 Other developments
    • 14.1.8 AIRWAY MANAGEMENT
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Product launches
    • 14.1.9 APNEA SCIENCES
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products offered
    • 14.1.10 ORAVANOSA
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products offered
    • 14.1.11 MYERSON LLC.
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products offered
    • 14.1.12 BRAEBON MEDICAL CORPORATION
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS
    • 14.2.2 THE SNORE RELIEVER COMPANY, LLC
    • 14.2.3 TOMED GMBH
    • 14.2.4 THE AURUM GROUP
    • 14.2.5 ERKODENT ENRICH KOPP GMBH
    • 14.2.6 OSCIMED SA
    • 14.2.7 SICAT GMBH & CO. KG
    • 14.2.8 GLIDEWELL
    • 14.2.9 APNOMED, INC.
    • 14.2.10 ZQUIET
    • 14.2.11 DREAM SYSTEMS DENTAL SLEEP LAB
    • 14.2.12 ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC
    • 14.2.13 ORTHOAPNEA
    • 14.2.14 DOC BRANDS, INC.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
Show more
Product Code: MD 6285

List of Tables

  • TABLE 1 SLEEP APNEA ORAL APPLIANCES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 SLEEP APNEA ORAL APPLIANCES MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 PREVALENCE OF SLEEP APNEA, BY COUNTRY, 2022-2024
  • TABLE 4 SUPPORTIVE AWARENESS INITIATIVES FOR EFFECTS OF UNTREATED SLEEP APNEA
  • TABLE 5 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA
  • TABLE 6 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023-2025 (USD)
  • TABLE 7 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL PRODUCTS, BY KEY PLAYER, 2023-2025
  • TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023-2025 (USD)
  • TABLE 9 SLEEP APNEA ORAL APPLIANCES MARKET: ROLE IN ECOSYSTEM
  • TABLE 10 SLEEP APNEA ORAL APPLIANCES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 IMPORT DATA FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 21 EXPORT DATA FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 22 SLEEP APNEA ORAL APPLIANCES MARKET: KEY CONFERENCES & EVENTS, 2025-2026
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES, BY END USERS (%)
  • TABLE 24 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES
  • TABLE 25 SLEEP APNEA ORAL APPLIANCES MARKET: END-USER ANALYSIS
  • TABLE 26 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT FEATURES AND COMPARATIVE ASSESSMENT
  • TABLE 27 SLEEP APNEA ORAL APPLIANCES MARKET: NEED GAP ANALYSIS
  • TABLE 28 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 29 ORAL APPLIANCES OFFERED BY KEY PLAYERS
  • TABLE 30 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 31 MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS
  • TABLE 32 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 33 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 34 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 35 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 37 READY-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS
  • TABLE 38 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 39 NORTH AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 40 EUROPE: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 42 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS
  • TABLE 43 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 44 NORTH AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 45 EUROPE: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 47 TONGUE-RETAINING DEVICES OFFERED BY KEY PLAYERS
  • TABLE 48 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 49 NORTH AMERICA: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 50 EUROPE: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 52 DAYTIME-NIGHTTIME APPLIANCES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 53 NORTH AMERICA: DAYTIME-NIGHTTIME APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 54 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 55 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES OFFERED BY KEY PLAYERS
  • TABLE 56 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 57 NORTH AMERICA: PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 58 EUROPE: PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 60 ONLINE OTC ORAL APPLIANCES OFFERED BY KEY PLAYERS
  • TABLE 61 ONLINE OTC ORAL APPLIANCES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: ONLINE OTC ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 63 EUROPE: ONLINE OTC ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: ONLINE OTC ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 65 PREVALENCE OF SLEEP APNEA, BY AGE GROUP & GENDER
  • TABLE 66 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 67 SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 69 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 71 SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 72 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 73 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 75 PREVALENCE OF SLEEP APNEA, BY AGE GROUP, 2021
  • TABLE 76 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 77 SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 79 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 81 SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40-60 YEARS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40-60 YEARS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 83 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40-60 YEARS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40-60 YEARS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 85 SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 86 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 87 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 89 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 90 SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 91 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 92 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 93 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 94 SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 96 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 98 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 99 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 100 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 102 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 103 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 104 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 105 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 107 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 108 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 109 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 111 SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 112 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 113 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 115 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 116 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 117 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 118 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (THOUSAND UNITS)
  • TABLE 119 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 120 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 121 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 122 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 123 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 124 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 125 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 126 KEY SLEEP APNEA PRODUCTS CURRENTLY AVAILABLE IN US
  • TABLE 127 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 128 US: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 129 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 130 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 132 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 133 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 134 KEY SLEEP APNEA PRODUCTS CURRENTLY AVAILABLE IN CANADA
  • TABLE 135 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 136 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 137 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 138 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 139 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 140 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 141 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 142 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 143 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 144 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 145 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 146 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 147 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 148 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 149 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 150 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 151 KEY SLEEP APNEA PRODUCTS CURRENTLY AVAILABLE IN GERMANY
  • TABLE 152 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 153 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 154 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 155 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 156 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 157 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 158 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 159 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 160 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 161 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 162 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 163 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 164 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 165 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 166 LEADING MARKET PLAYERS & PRODUCTS REIMBURSED BY SOCIAL SECURITY OF FRANCE
  • TABLE 167 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 168 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 169 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 170 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 171 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 172 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 173 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 174 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 175 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 176 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 177 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 178 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 179 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 180 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 181 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 182 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 183 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 184 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 185 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 186 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 187 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 188 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 189 REST OF EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 190 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 191 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 192 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 193 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 194 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 196 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 197 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 199 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 200 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 202 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 203 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 204 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 205 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 206 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 207 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 208 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 209 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 210 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 211 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 212 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 213 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 214 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 215 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 216 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 217 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 218 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 219 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 220 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 221 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 222 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 223 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 224 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 225 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 226 REST OF ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 227 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 228 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 229 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 230 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 231 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 232 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 233 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 234 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 235 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 236 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 237 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 238 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 239 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 240 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 241 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 242 MIDDLE EAST & AFRICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 243 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 244 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 245 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 246 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 247 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 248 GCC COUNTRIES: MACROECONOMIC INDICATORS
  • TABLE 249 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 250 GCC COUNTRIES: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 251 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022-2030 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022-2030 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 254 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)
  • TABLE 255 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 256 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET
  • TABLE 257 SLEEP APNEA ORAL APPLIANCES MARKET: DEGREE OF COMPETITION
  • TABLE 258 SLEEP APNEA ORAL APPLIANCES MARKET: REGION FOOTPRINT
  • TABLE 259 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT FOOTPRINT
  • TABLE 260 SLEEP APNEA ORAL APPLIANCES MARKET: PURCHASE TYPE FOOTPRINT
  • TABLE 261 SLEEP APNEA ORAL APPLIANCES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 262 SLEEP APNEA ORAL APPLIANCES MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • TABLE 263 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 264 SLEEP APNEA ORAL APPLIANCES MARKET: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 265 SLEEP APNEA ORAL APPLIANCES MARKET: EXPANSIONS, JANUARY 2021-APRIL 2025
  • TABLE 266 SLEEP APNEA ORAL APPLIANCES MARKET: OTHER DEVELOPMENTS, JANUARY 2021-APRIL 2025
  • TABLE 267 SOMNOMED: COMPANY OVERVIEW
  • TABLE 268 SOMNOMED: PRODUCTS OFFERED
  • TABLE 269 RESMED: COMPANY OVERVIEW
  • TABLE 270 RESMED: PRODUCTS OFFERED
  • TABLE 271 RESMED: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 272 RESMED: EXPANSIONS, JANUARY 2021-APRIL 2025
  • TABLE 273 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 274 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 275 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 276 DYNAFLEX: COMPANY OVERVIEW
  • TABLE 277 DYNAFLEX: PRODUCTS OFFERED
  • TABLE 278 DYNAFLEX: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 279 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW
  • TABLE 280 VIVOS THERAPEUTICS, INC.: PRODUCTS OFFERED
  • TABLE 281 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 282 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 283 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021-APRIL 2025
  • TABLE 284 VIVOS THERAPEUTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021-APRIL 2025
  • TABLE 285 OPENAIRWAY: COMPANY OVERVIEW
  • TABLE 286 OPENAIRWAY: PRODUCTS OFFERED
  • TABLE 287 OPENAIRWAY: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 288 PANTHERA DENTAL: COMPANY OVERVIEW
  • TABLE 289 PANTHERA DENTAL: PRODUCTS OFFERED
  • TABLE 290 PANTHERA DENTAL: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
  • TABLE 291 PANTHERA DENTAL: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 292 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021-APRIL 2025
  • TABLE 293 AIRWAY MANAGEMENT: COMPANY OVERVIEW
  • TABLE 294 AIRWAY MANAGEMENT: PRODUCTS OFFERED
  • TABLE 295 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021-APRIL 2025
  • TABLE 296 APNEA SCIENCES: COMPANY OVERVIEW
  • TABLE 297 APNEA SCIENCES: PRODUCTS OFFERED
  • TABLE 298 ORAVANOSA: COMPANY OVERVIEW
  • TABLE 299 ORAVANOSA: PRODUCTS OFFERED
  • TABLE 300 MYERSON LLC.: COMPANY OVERVIEW
  • TABLE 301 MYERSON LLC.: PRODUCTS OFFERED
  • TABLE 302 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW
  • TABLE 303 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED
  • TABLE 304 MPOWRX HEALTH & WELLNESS PRODUCTS: COMPANY OVERVIEW
  • TABLE 305 THE SNORE RELIEVER COMPANY, LLC.: COMPANY OVERVIEW
  • TABLE 306 TOMED GMBH: COMPANY OVERVIEW
  • TABLE 307 THE AURUM GROUP: COMPANY OVERVIEW
  • TABLE 308 ERKODENT ENRICH KOPP GMBH: COMPANY OVERVIEW
  • TABLE 309 OSCIMED SA: COMPANY OVERVIEW
  • TABLE 310 SICAT GMBH & CO.KG: COMPANY OVERVIEW
  • TABLE 311 GLIDEWELL: COMPANY OVERVIEW
  • TABLE 312 APNOMED, INC.: COMPANY OVERVIEW
  • TABLE 313 ZQUIET: COMPANY OVERVIEW
  • TABLE 314 DREAM SYTEMS DENTAL SLEEP LAB: COMPANY OVERVIEW
  • TABLE 315 ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC: COMPANY OVERVIEW
  • TABLE 316 ORTHOAPNEA: COMPANY OVERVIEW
  • TABLE 317 DOC BRANDS, INC.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MARKETS & REGIONS COVERED
  • FIGURE 2 SLEEP APNEA ORAL APPLIANCES MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 SLEEP APNEA ORAL APPLIANCES MARKET: TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 SLEEP APNEA ORAL APPLIANCES MARKET: IMPACT ANALYSIS
  • FIGURE 9 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 10 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 11 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE MARKET
  • FIGURE 17 MANDIBULAR ADVANCEMENT DEVICES SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 18 MANDIBULAR ADVANCEMENT DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US IN 2024
  • FIGURE 19 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 20 SLEEP APNEA ORAL APPLIANCES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING & ASSEMBLY PHASES
  • FIGURE 22 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION IS THE PREFERRED STRATEGY OF PROMINENT COMPANIES
  • FIGURE 23 SLEEP APNEA ORAL APPLIANCES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 24 SLEEP APNEA ORAL APPLIANCES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 25 SLEEP APNEA ORAL APPLIANCES MARKET: PATENT ANALYSIS, JANUARY 2015-DECEMBER 2023
  • FIGURE 26 SLEEP APNEA ORAL APPLIANCES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES
  • FIGURE 28 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES
  • FIGURE 29 AI USE CASES
  • FIGURE 30 SLEEP APNEA ORAL APPLIANCES MARKET: INVESTMENT & FUNDING SCENARIO 2019-2024
  • FIGURE 31 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET, 2022-2024 (USD MILLION)
  • FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET (2024)
  • FIGURE 35 RANKING OF KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET, 2024
  • FIGURE 36 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 37 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY FOOTPRINT
  • FIGURE 38 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2024
  • FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 40 EV/EBITDA OF KEY VENDORS
  • FIGURE 41 SLEEP APNEA ORAL APPLIANCES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 42 SOMNOMED: COMPANY SNAPSHOT (2024)
  • FIGURE 43 RESMED: COMPANY SNAPSHOT (2023)
  • FIGURE 44 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023)
  • FIGURE 45 VIVOS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2024)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!